Mesoblast MESO
NASDAQ MESO
$17.29 +0.15 (+0.88%)
As of: Sep 4, 2026 · 3:20 PM EDT

Mesoblast (MESO) Other Non Operating Income (2014 - 2023)

Mesoblast (MESO) posted Other Non Operating Income of $10.3 million for Q4 2025, up 596.67% sequentially from $1.5 million in Q4 2023.

Analysis

Mesoblast (MESO) Other Non Operating Income (2014 - 2023) Analysis & Trends

Mesoblast has reported Other Non Operating Income for 9 years, with the latest figure at $10.3 million in Q4 2025.

  • Quarterly Other Non Operating Income changed N/A year-over-year to $10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 million (changed N/A YoY) and the FY2022 annual result came in at $5.9 million, up 486.88% from the prior year.
  • Other Non Operating Income grew to $10.3 million in Q4 2025 per MESO's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $10.3 million in Q4 2025 and troughed at -$401000.0 in Q3 2022.
  • A 4-year average of $2.2 million and a median of $1.5 million in 2022 frame the typical range for Other Non Operating Income.
  • The widest YoY moves for Other Non Operating Income: up 138.05% in 2021, down 185.54% in 2021.
  • Over 4 years, Other Non Operating Income stood at $2.2 million in 2021, then plunged by 31.55% to $1.5 million in 2022, then changed by 0.0% to $1.5 million in 2023, then soared by 596.67% to $10.3 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $10.3 million, $1.5 million, and $1.5 million for Q4 2025, Q4 2023, and Q1 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.13 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -2.57 Mn
Mar 31, 2023 -517,000.00
Dec 31, 2022 -311,000.00
Sep 30, 2022 -401,000.00
Jun 30, 2022 526,000.00
Mar 31, 2022 896,000.00
Dec 31, 2021 2.15 Mn
Sep 30, 2018 -151,000.00
Sep 30, 2017 75,000.00
Sep 30, 2016 -9,000.00
Sep 30, 2015 -257,000.00
Sep 30, 2014 4.63 Mn